Monoclonal antibodies, shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

Monoclonal antibodies,shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

Monoclonal antibodies, shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

Monoclonal antibodies, shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

Monoclonal antibodies, shown here with the antigens attached to the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

Monoclonal antibodies, shown here alone, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.

DNA.

DNA.

Researchers have found ways to take human stem cells from body tissues other than fetal tissue. These cells may be used to replicate numerous different body cells in order to treat a number of diseases and conditions of the body.

Researchers have found ways to take human stem cells from body tissues other than fetal tissue. These cells may be used to replicate numerous different body cells in order to treat a number of diseases and conditions of the body.

This animation depicts a number of fetus clones.

DNA running through an egg, which is being fertilized by sperm.

DNA running through an egg, which is being fertilized by sperm. A robot hand is involved. This image could be used to illustrate the concepts of cloning, artifical insemination, genetic manipulation, cybernetics, nano technology, robotics, or futuristic bioengineering.

Two robot hands working on an egg, which is being fertilized by sperm. This image could be used to illustrate the concepts of cloning, artifical insemination, genetic manipulation, cybernetics, nano technology, robotics, or futuristic bioengineering.

Artistic illustration of the DNA double helix as made out of a reflective metal. The model shows the two strands of nucleotide monomers represented as bars connecting the two helices.

This illustration pays homage to the famous drawing "Vitruvian Man" by Leonardo Da Vinci. In the drawing, Da Vinci portrays the proportions of man, or the "Canon of Proportions." The drawing is based on the correlations of ideal human proportions with geometric proportions described by the ancient Roman architect Vitruvius in his treatise "De Architectura." Vitruvius described the human figure as being the principal source of proportion among the classical orders of architecture. Additional elements in this illustration include a wrap-around depiction of molecular DNA and a background of the alphabetical symbols for the four nucleotides, guanine, cytosine, adenine and thymine, that compose the organic base pairs of the DNA double-helix chain.

This illustration pays homage to the famous drawing "Vitruvian Man" by Leonardo Da Vinci. In the drawing, Da Vinci portrays the proportions of man, or the "Canon of Proportions." The drawing is based on the correlations of ideal human proportions with geometric proportions described by the ancient Roman architect Vitruvius in his treatise "De Architectura." Vitruvius described the human figure as being the principal source of proportion among the classical orders of architecture. Additional elements in this illustration include a depiction of the molecular DNA double helix.

This illustration pays homage to the famous drawing "Vitruvian Man" by Leonardo Da Vinci. In the drawing, Da Vinci portrays the proportions of man, or the "Canon of Proportions." The drawing is based on the correlations of ideal human proportions with geometric proportions described by the ancient Roman architect Vitruvius in his treatise "De Architectura." Vitruvius described the human figure as being the principal source of proportion among the classical orders of architecture. In this illustration, the figure of a man is replaced by that of a woman. Additional elements include a representation of the DNA molecular double-helix.

This illustration pays homage to the famous drawing "Vitruvian Man" by Leonardo Da Vinci. In the drawing, Da Vinci portrays the proportions of man, or the "Canon of Proportions." The drawing is based on the correlations of ideal human proportions with geometric proportions described by the ancient Roman architect Vitruvius in his treatise "De Architectura." Vitruvius described the human figure as being the principal source of proportion among the classical orders of architecture. In this illustration, the figure of a man is replaced by that of a woman. Additional elements include a depiction of the molecular DNA double heli; the cascade of foreground molecules represent the molecular structure of the four nucleotides present in the organic base pairs of DNA: thymine, cytosine, guanine and adenine.

This illustration pays homage to the famous drawing "Vitruvian Man" by Leonardo Da Vinci. In the drawing, Da Vinci portrays the proportions of man, or the "Canon of Proportions." The drawing is based on the correlations of ideal human proportions with geometric proportions described by the ancient Roman architect Vitruvius in his treatise "De Architectura." Vitruvius described the human figure as being the principal source of proportion among the classical orders of architecture. In this illustration, the figure of a man is replaced by that of a woman. Additional elements include a depiction of molecular DNA and a cascade of foreground molecules represent the molecular structure of the four nucleotides present in the organic base pairs of DNA: Thymine, Cytosine, Guanine and Adenine.